Close Menu

NEW YORK – Inivata said today that it has signed a distribution agreement with IPS Genomix to provide its InVisionFirst-Lung and InVisionSeq liquid biopsy tests to cancer patients and partners in the Middle East and Africa.

Under the agreement, IPS Genomix — a part of Integrated Pharma Solutions — will facilitate patient access through both insurers and in the private pay market in the United Arab Emirates, Qatar, Kuwait, Bahrain, Lebanon, Jordan, Egypt, and the Kingdom of Saudi Arabia.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.